Welcome to Biosensors International Group, Ltd. Investor Relations

Biosensors International Group, Ltd. develops, manufactures and commercializes innovative medical devices used in interventional cardiology and critical care procedures.

Jan 13, 2012	Date Of Release Of Financial Results For The Third Quarter Of Fiscal Year 2012 Ended 31 December 2011
Dec 12, 2011	Slides For Analyst Presentation On 12 December 2011
Nov 30, 2011	Conversion Of US$120,043,000 Principal Amount Of 4% Convertible Notes Due 2014

Jan 06, 2012	Biosensors Appoints President Of Biosensors Japan
Dec 30, 2011	Biosensors International To Participate In The 30th Annual J.P. Morgan Healthcare Conference
Nov 30, 2011	Shandong Weigao Exercises Convertible Notes And Becomes Biosensors' Single Largest Shareholder

Stock Quotes

SGX Symbol:	B20
Currency:	SGD
Last Done:	1.585
Volume ('000):	1,171
Change:	+0.005
% Change:	0.3
Day's Range:	1.570 - 1.585
52 Weeks' Range:	0.960 - 1.600

Quotes Delayed 20 Minutes
Updated: 27 Jan 2012 17:04

Upcoming Events

Q3 FY12 Financial Results Briefing Live Webcast
Wednesday, 08 February 2012

Biosensors will announce its results for the third quarter of its financial year 2012, ended 31 December 2011, on 08 February 2012 after trading hours on the Singapore Stock Exchange.

Co-CEOs Dr. Jack Wang and Mr. Jeffrey B. Jump, and CFO Mr. Ronald H. Ede will host an analyst conference call on that day at 7pm Singapore Time (GMT +8) to discuss the financial results and provide an update on the Company's progress.

Click here to view the webcast

A|A|AText Size

Valid HTML Valid CSS